Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about EXEL

Recent news which mentions EXEL

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023

July 20, 2023

3 No-Brainer Stocks to Buy With $200 Right Now

June 21, 2023

The Smartest Stocks to Buy With $20 Right Now and Hold Forever

May 29, 2023

2 Under-the-Radar Biotech Stocks to Buy in 2023

May 24, 2023

2 Unstoppable Growth Stocks to Buy in 2023 and Beyond

May 20, 2023

Nasdaq Bear Market: 5 Exceptional Growth Stocks You'll Regret Not Buying on the Dip

May 13, 2023

8 Analysts Have This to Say About Exelixis

May 10, 2023

Exelixis (EXEL) Q1 2023 Earnings Call Transcript

May 10, 2023

Exelixis: Q1 Earnings Insights

May 09, 2023

Amid Proxy Challenge From Farallon, Exelixis' Board Member Resigns

May 08, 2023

The Smartest Stocks to Buy With $20 Right Now and Hold Forever

April 22, 2023

Nasdaq Bear Market: 5 Sensational Growth Stocks You'll Regret Not Buying on the Dip

April 22, 2023

What 9 Analyst Ratings Have To Say About Exelixis

April 12, 2023

2 Under-the-Radar Biotech Stocks to Buy in 2023

April 05, 2023

Facebook Turns To Generative AI For Help, FedEx Consolidates, UBS Executives Say Surprise Credit Suisse Deal 'Major Challenge:' Today's Top Stories

April 05, 2023

Farallon Capital Might Undertake Proxy Fight Against Exelixis, Nominates Three Directors

April 05, 2023

2 Incredible Stocks to Buy With Less Than $25

April 04, 2023

Why Exelixis Stock Leaped More Than 4% Higher Today

March 20, 2023

Analyst Ratings for Exelixis

March 20, 2023

3 Beaten-Down Stocks That Could Soar This Year

March 18, 2023

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector

March 15, 2023

Nasdaq Bear Market: 5 Stunning Growth Stocks You'll Regret Not Buying on the Dip

March 11, 2023

2 Stocks to Buy With Less Than $20

March 10, 2023

Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023

March 09, 2023

The Latest Analyst Ratings for Exelixis

March 03, 2023

Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo

March 03, 2023

US Stocks Look To Snap String Of Weekly Losses As Futures Signal Positive Start Ahead Of Service Sector Data, Fed Speeches

March 03, 2023

Dell, Zscaler, Marvell Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session

March 03, 2023

Nasdaq Bear Market: 5 Magnificent Growth Stocks You'll Regret Not Buying on the Dip

February 18, 2023

Bristol Myers Squibb-Exelixis Highlight Three-Year Follow Up Data From Opdivo+Cabometyx Combo Therapy In Kidney Cancer

February 14, 2023

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.